Allergy Immunotherapy in India: How Allergy Shots Work

What is allergy immunotherapy and how does it work?

Allergy immunotherapy in India is a long-term treatment that reduces sensitivity to allergens by gradually exposing the immune system to increasing doses of the substance causing the reaction. Unlike antihistamines that only suppress symptoms, immunotherapy targets the underlying immune response — offering the possibility of sustained relief even after the course is complete.

At Pulmo Vista in New Delhi, allergy immunotherapy is offered as part of a comprehensive allergy diagnosis and treatment programme that includes skin prick testing, allergen identification, and personalised desensitisation protocols.

  • Immunotherapy works by training the immune system to tolerate specific allergens
  • Available in two main forms: subcutaneous injections (SCIT) and sublingual drops or tablets (SLIT)
  • Treatment typically spans 3 to 5 years for lasting benefit
  • Effective for allergic rhinitis, allergic asthma, insect venom allergy, and certain food allergies
  • Requires allergen identification through skin prick or blood testing before starting
  • Supervised by a specialist — not a self-administered over-the-counter treatment

Tip: Immunotherapy does not produce instant results. Most patients notice meaningful improvement after 6–12 months of consistent treatment.

Types of allergy immunotherapy available in India

Two primary forms of allergy immunotherapy are practised in India. The choice between them depends on the allergen type, patient age, severity of allergy, and clinical assessment by a specialist.

Type Method Frequency Best For
SCIT (Allergy Shots) Subcutaneous injection given in clinic Weekly (build-up), then monthly (maintenance) Pollen, dust mites, pet dander, insect venom
SLIT (Sublingual) Drops or tablets placed under the tongue Daily, can be taken at home Dust mites, grass pollen, certain moulds

Both SCIT and SLIT are practised in India. Sublingual immunotherapy (SLIT) is increasingly preferred for paediatric patients and those who cannot visit a clinic frequently. SCIT remains the more extensively studied option and is considered the reference standard for allergen desensitisation.

Patients with allergic asthma may benefit from immunotherapy alongside their standard inhaler regimen — a specialist assessment is essential before starting.

Who is a good candidate for allergy immunotherapy?

Not every allergy patient requires immunotherapy. A specialist will assess whether the benefits outweigh the time commitment and potential risks. The following criteria generally indicate suitability:

  • Symptoms persist for more than 3 months per year despite medication
  • Antihistamines or nasal steroids provide inadequate relief
  • Confirmed sensitisation to a specific allergen via skin prick or IgE blood test
  • Allergic rhinitis, allergic conjunctivitis, or allergic asthma with identifiable triggers
  • Insect venom allergy with a history of systemic reactions
  • Patients who wish to reduce long-term dependence on daily medications
  • Children aged 5 and above (SLIT) or 7 and above (SCIT) in most clinical protocols

Warning: Immunotherapy is generally not recommended for patients with severe or unstable asthma, significant cardiovascular disease, or those on beta-blocker medication. Always disclose your full medical history to your specialist before starting.

Patients with COPD or other chronic respiratory conditions should undergo a thorough pulmonary evaluation before any immunotherapy protocol is initiated.

How is allergy diagnosed before starting immunotherapy?

Accurate allergen identification is the foundation of effective immunotherapy. Treating the wrong allergen produces no benefit. At Pulmo Vista, the diagnostic pathway uses advanced equipment to pinpoint the specific triggers before any treatment plan is designed.

  • Skin Prick Test (SPT): Small amounts of common allergens are introduced to the skin surface; a raised wheal indicates sensitisation. Results are available within 20 minutes.
  • Specific IgE Blood Test (RAST/ImmunoCAP): Measures allergen-specific antibodies in the blood — useful when skin testing is not feasible.
  • Pulmonary Function Test (PFT): Assesses lung function to determine whether allergic asthma is present and its severity.
  • FeNO (Fractional Exhaled Nitric Oxide) Test: Measures airway inflammation — helps distinguish allergic from non-allergic airway disease.
  • Detailed clinical history: Seasonal patterns, occupational exposures, pet ownership, and dietary triggers are all reviewed.

Pulmo Vista’s in-clinic setup includes a Skin Prick Allergy Testing Setup, a Complete PFT System, and a FeNO Analyzer — enabling comprehensive respiratory and allergy assessment under one roof in New Delhi.

Allergy immunotherapy treatment options: SCIT vs SLIT compared

Once the allergen is confirmed, the specialist designs a personalised immunotherapy schedule. The table below compares the two main approaches available for allergy immunotherapy in India:

Factor SCIT (Allergy Shots) SLIT (Sublingual)
Administration Clinic injection Home drops/tablets
Build-up phase 6–12 months (weekly visits) Gradual dose increase at home
Maintenance phase Monthly injections for 3–5 years Daily dosing for 3–5 years
Supervision required Yes — 30-min observation post-injection Initial doses supervised; rest at home
Evidence base Extensive, decades of data Growing, particularly for dust mite and grass pollen
Suitability Adults and older children; multiple allergens Children from age 5; single allergen protocols

Anti-allergic medications — including antihistamines, intranasal corticosteroids, and leukotriene receptor antagonists — are often continued during the build-up phase of immunotherapy to manage breakthrough symptoms. Your specialist will advise on the appropriate combination for your case. For a broader view of pulmonology and respiratory care at Pulmo Vista, including conditions that overlap with allergy, visit the speciality page.

When should you see an allergy specialist in New Delhi?

Many patients manage mild allergies with over-the-counter antihistamines for years without seeking specialist input. However, certain thresholds indicate that a formal allergy evaluation — and potentially immunotherapy — is warranted:

  • Nasal or eye allergy symptoms persist for more than 4 weeks per season despite antihistamine use
  • Symptoms are present year-round and interfere with sleep, work, or daily activities
  • You have required more than two courses of oral steroids in a single year for allergy-related symptoms
  • Allergy triggers asthma attacks or worsens existing asthma control
  • You have experienced a systemic reaction (anaphylaxis) to an insect sting
  • Skin eczema or urticaria is recurrent and linked to environmental or food triggers
  • You wish to reduce or stop long-term daily allergy medication

Tip: Early specialist referral improves immunotherapy outcomes. Starting treatment before allergy-driven asthma becomes established may reduce the risk of progression to more severe respiratory disease.

How Pulmo Vista in New Delhi supports allergy immunotherapy

Pulmo Vista, located at R45, Block R, Greater Kailash I, New Delhi — 110048, brings together advanced respiratory diagnostics and specialist allergy care in a single clinic setting. With 10+ years of experience in respiratory and critical care management, the clinical team is equipped to assess, diagnose, and manage the full spectrum of allergic and pulmonary conditions.

The clinic’s technology suite supports every stage of the allergy immunotherapy pathway:

  • Skin Prick Allergy Testing Setup for rapid, accurate allergen identification
  • Complete Pulmonary Function Test (PFT) System to assess baseline lung function
  • FeNO Analyzer to quantify airway inflammation before and during treatment
  • Forced Oscillation Technique (FOT) Machine for non-invasive airway resistance measurement
  • Personalised SCIT and SLIT protocols designed around confirmed allergen sensitisation

Patients with overlapping conditions — such as allergic rhinitis combined with sleep-disordered breathing — benefit from the clinic’s integrated approach, which addresses respiratory health comprehensively rather than in isolation.

To discuss whether allergy immunotherapy is appropriate for your situation, use the booking form on this page or contact the clinic directly.

Book a consultation at Pulmo Vista

Use the booking form on this page, or reach out directly:

Call: 8448046304

WhatsApp: 8448046304

Frequently Asked Questions

Q. How well does immunotherapy work for allergies?

Clinical evidence shows that allergen immunotherapy significantly reduces symptom severity and medication use in patients with allergic rhinitis, allergic asthma, and insect venom allergy. Many patients experience sustained relief that persists for years after completing the course. Effectiveness depends on correct allergen identification, adherence to the full treatment schedule, and specialist supervision throughout.

Q. How long does allergy immunotherapy take in India?

Allergy immunotherapy in India typically follows a two-phase schedule. The build-up phase involves weekly doses over 6 to 12 months. The maintenance phase then continues with monthly injections (SCIT) or daily sublingual doses (SLIT) for a total treatment duration of 3 to 5 years. Patients often notice symptom improvement within the first 6 to 12 months of starting treatment.

Q. Is sublingual immunotherapy better than allergy injections?

Neither is universally superior — the choice depends on the allergen, patient age, and lifestyle. SCIT (injections) has a longer evidence base and is effective for a wider range of allergens including insect venom. SLIT (sublingual drops or tablets) is more convenient, can be taken at home, and is preferred for children. A specialist assessment is needed to determine which approach suits your specific allergy profile.

Q. What is the cost of allergy shots in India?

The cost of allergy immunotherapy in India varies depending on the allergen extract used, the number of allergens included in the protocol, and the clinic. For accurate pricing relevant to your specific allergen profile and treatment plan, use the booking form on this page or call Pulmo Vista directly on 8448046304 to discuss your case with a specialist.

Q. What are common anti-allergic medications used alongside immunotherapy in India?

During the build-up phase of immunotherapy, specialists commonly prescribe antihistamines (such as cetirizine or fexofenadine), intranasal corticosteroid sprays, and leukotriene receptor antagonists to control breakthrough symptoms. These are typically tapered as immunotherapy takes effect. The specific combination is determined by your specialist based on symptom severity and the allergens being treated.

Q. Is allergy immunotherapy available in Delhi, and who should I consult?

Yes, allergy immunotherapy — both SCIT and SLIT — is available in New Delhi. Pulmo Vista at Greater Kailash I offers a full allergy diagnostic and immunotherapy service, including skin prick testing, PFT, and FeNO analysis. To find out whether you are a suitable candidate, use the booking form on this page or contact the clinic on 8448046304.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top